Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02126 JW THERAP-B
RT Nominal down5.100 -0.030 (-0.585%)
Latest  |  Final  |  Interim
Non-current Assets
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others207,488-10.716%232,392285,331348,107319,894
Land & other Lease Assets32,784-20.980%41,48855,80045,11245,784
Intangible Assets417,539-28.377%582,966711,215893,684816,289
Interests in Asso. & JCEs0--0000
Other Non-current Assets14,585-1.751%14,84526,26719,27639,599

672,396-22.863%871,6911,078,6131,306,1791,221,566
Current Assets
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Inventories67,021114.419%31,25734,77840,15931,402
Trade Receivables25,055--005,3050
Cash & Bank Balances646,880-14.589%757,3751,005,9091,383,3361,834,399
Other Current Assets8,089-59.638%20,04126,79756,36829,239
Assets Held for Sale0--0000

747,045-7.621%808,6731,067,4841,485,1681,895,040
Current Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Trade Payables44,6662010.870%2,1163,2697,6042,565
S-T Debt & Leases331,976-11.769%376,259121,005152,90020,186
Other Current Liabilities93,7078.108%86,679140,195150,331176,149
Liab asso w/ Assets Held for Sale0--0000

470,3491.139%465,054264,469310,835198,900
Net Current Assets276,696-19.476%343,619803,0151,174,3331,696,140
Total Assets Less Current Liabilities949,092-21.905%1,215,3101,881,6282,480,5122,917,706
Non-current Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
L-T Debt & Leases40,484-12.268%46,145197,790126,228126,849
Other Non-current Liabilities0--0000

40,484-12.268%46,145197,790126,228126,849
Capital and Reserves
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
  Share Capital270.000%27272727
  Reserves908,581-22.286%1,169,1381,683,8112,354,2572,790,830
  Others0--0000
Shareholders' Funds908,608-22.286%1,169,1651,683,8382,354,2842,790,857
Non-controlling Interests0--0000
Others0--0000

908,608-22.286%1,169,1651,683,8382,354,2842,790,857
Commitments and Contingent Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Commitments----004,34515,665
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 11/09/2025 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB -267,265
%Change11.237%
EPS / (LPS)RMB -0.640
NBV Per Share (¥)RMB 2.183
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.